Cargando…

Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Immune checkpoint inhibitors (ICIs) can elicit toxicities by inhibiting negative regulators of adaptive immunity. Sometimes, management of toxicities may require systemic glucocorticoids. We performed a systematic review and meta-analysis of published studies to evaluate the correlation between ster...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrelli, Fausto, Signorelli, Diego, Ghidini, Michele, Ghidini, Antonio, Pizzutilo, Elio Gregory, Ruggieri, Lorenzo, Cabiddu, Mary, Borgonovo, Karen, Dognini, Giuseppina, Brighenti, Matteo, De Toma, Alessandro, Rijavec, Erika, Garassino, Marina Chiara, Grossi, Francesco, Tomasello, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139305/ https://www.ncbi.nlm.nih.gov/pubmed/32120803 http://dx.doi.org/10.3390/cancers12030546

Ejemplares similares

Impact of Use of Gastric-Acid Suppressants and Oral Anti-Cancer Agents on Survival Outcomes: A Systematic Review and Meta-Analysis
por: Indini, Alice, et al.
Publicado: (2020)

Strategies for Increasing the Effectiveness of Aromatase Inhibitors in Locally Advanced Breast Cancer: An Evidence-Based Review on Current Options
por: Grizzi, Giulia, et al.
Publicado: (2020)

Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies
por: Petrelli, Fausto, et al.
Publicado: (2021)

Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses
por: Petrelli, Fausto, et al.
Publicado: (2023)

Lactobacillus Kefiri LKF01 (Kefibios(®)) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: A Prospective Study
por: Ghidini, Michele, et al.
Publicado: (2021)

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022)

COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-Analysis
por: Oldani, Simone, et al.
Publicado: (2022)

Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
por: Petrelli, Fausto, et al.
Publicado: (2019)

Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022)

Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?
por: Ghidini, Michele, et al.
Publicado: (2019)

Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials
por: Petrelli, Fausto, et al.
Publicado: (2016)

Survival of Patients Treated with Antibiotics and Immunotherapy for Cancer: A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2020)

The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score
por: Ghidini, Michele, et al.
Publicado: (2021)

Timing of Adjuvant Chemotherapy and Survival in Colorectal, Gastric, and Pancreatic Cancer. A Systematic Review and Meta-Analysis
por: Petrelli, Fausto, et al.
Publicado: (2019)

Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review
por: Indini, Alice, et al.
Publicado: (2021)

Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review
por: Petrelli, Fausto, et al.
Publicado: (2021)

Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Biliary tract cancer: current challenges and future prospects
por: Ghidini, Michele, et al.
Publicado: (2018)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts
por: Indini, Alice, et al.
Publicado: (2020)

Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic
por: Indini, Alice, et al.
Publicado: (2020)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies
por: Petrelli, Fausto, et al.
Publicado: (2022)

Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
por: Khakoo, Shelize, et al.
Publicado: (2021)

Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Pusceddu, Sara, et al.
Publicado: (2019)

Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studies
por: Petrelli, Fausto, et al.
Publicado: (2021)

Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data
por: Ratti, Margherita, et al.
Publicado: (2019)

Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies
por: Petrelli, Fausto, et al.
Publicado: (2018)

Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023)

A Review of Clinical Practice Guidelines and Treatment Recommendations for Cancer Care in the COVID-19 Pandemic
por: Zaniboni, Alberto, et al.
Publicado: (2020)

The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023)

Coronavirus infection and immune system: An insight of COVID-19 in cancer patients
por: Indini, Alice, et al.
Publicado: (2020)

Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
por: Grizzi, Giulia, et al.
Publicado: (2023)

Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection
por: Parati, Maria Chiara, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
por: Pizzutilo, Elio Gregory, et al.
Publicado: (2023)

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario
por: Trevisani, Francesco, et al.
Publicado: (2022)

1765P Developing a risk assessment score for cancer patients during the COVID-19 pandemic
por: Indini, A., et al.
Publicado: (2020)

1689P The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists
por: Ghidini, M., et al.
Publicado: (2020)

Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
por: Tomasello, G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0qt56m5hv1cbcugda6rg6t499s